3 completed, 2 active not recruiting, 1 not yet recruiting, 1 recruiting. 2 Phase 4, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Varicella-zoster Virus: new trials by email Literature Review of Varicella-zoster Virus trials Research Report on Varicella-zoster Virus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial Two-dose M0-M2 vaccination schedule, Two-dose M0-M6 vaccination schedule - Vaccine, Varicella-zoster Virus | Phase 4 | Not yet recruiting | University Hospital, Toulouse | 160 | 2026-10-20 | 2026-09-14 |
| Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above ABO1108, Placebo - Varicella-zoster Virus | Phase 3 | Recruiting | Suzhou Abogen Biosciences Co., Ltd. | 18000 | 2026-06-27 | 2026-09-14 |
| Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above ABO1108, Placebo - Varicella-zoster Virus | Phase 2 | Active not recruiting | Suzhou Abogen Biosciences Co., Ltd. | 300 | 2025-11-15 | 2026-05-11 |
| Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above ABO1108, Placebo, SHINGRIX - Varicella-zoster Virus | Phase 1 | Active not recruiting | Suzhou Abogen Biosciences Co., Ltd. | 180 | 2025-05-27 | 2026-05-11 |
| Review of Human Herpes Viruses in Burns Review of the Literature for Human Herpes Virus infections - Human Herpes Virus, Herpes Simplex Virus | Completed | The University of Texas Medical Branch, Galveston | 10267 | 2015-03-01 | 2015-05-22 | |
| Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis Serum sample - Viral Hepatitis Vaccines, Hepatitis A | Completed | GlaxoSmithKline | 3658 | 2010-03-01 | 2011-01-25 | |
| The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children VZV vaccination - HIV Infections, Varicella-zoster Virus | Phase 4 | Completed | The HIV Netherlands Australia Thailand Research Collaboration | 60 | 2009-06-01 | 2020-07-17 |
Chickenpox (7) · Herpes Simplex (2) · Burns (1) · HIV Infections (1) · Hepatitis A (1) · Herpes Zoster (1) · Multiple Sclerosis (1) · Whooping Cough (1)
DNA Virus Infections (7) · Herpesviridae Infections (7) · Infections (7) · Varicella Zoster Virus Infection (7) · Virus Diseases (7) · Immune System Diseases (2) · RNA Virus Infections (2) · Skin Diseases (2) · Skin Diseases, Infectious (2) · Skin Diseases, Viral (2) · Skin and Connective Tissue Diseases (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1)
Suzhou Abogen Biosciences Co., Ltd. (3) · GlaxoSmithKline (1) · The HIV Netherlands Australia Thailand Research Collaboration (1) · The University of Texas Medical Branch, Galveston (1) · University Hospital, Toulouse (1)
China (3) · France (1) · Mexico (1) · Thailand (1)
David N Herndon, MD, FACS (1) · Jonathan Ciron, MD (1) · Teng Huang (1)
2025 (1)